New Issue: Barclays prices $510,000 notes linked to pharmaceutical stocks

By Angela McDaniels

Tacoma, Wash., May 21 – Barclays Bank plc priced $510,000 of 0% notes due May 19, 2022 linked to the least performing of the common stocks of Merck & Co., Inc., Pfizer Inc. and Johnson & Johnson, according to a 424B2 filing with the Securities and Exchange Commission.

If the least-performing stock’s return is greater than or equal to zero, the payout at maturity will be par plus the lesser of the least-performing stock’s return and 25%.

If the least-performing stock’s return is less than zero, the payout will be par.

Barclays is the agent.

Issuer:	Barclays Bank plc
Issue:	Notes
Underlying stocks:	Merck & Co., Inc. (Symbol: MRK), Pfizer Inc. (Symbol: PFE) and Johnson & Johnson (Symbol: JNJ)
Amount:	$510,000
Maturity:	May 19, 2022
Coupon:	0%
Price:	Par
Payout at maturity:	If least-performing stock’s return is greater than or equal to zero, par plus lesser of least-performing stock’s return and 25%; if least-performing stock’s return is less than zero, par
Initial share prices:	$78.72 for Merck, $41.47 for Pfizer and $138.61 for Johnson & Johnson
Pricing date:	May 17
Settlement date:	May 22
Agent:	Barclays
Fees:	3.25%
Cusip:	06747MUJ3

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.